Roche Diagnostics received CE mark approval for its cobas® mass spectrometry solution, providing fully-automated, integrated, and standardised clinical mass spectrometry for laboratories worldwide. Until now, mass spectrometry has only been offered by specialist laboratories. This approval will broaden access to routine labs, enabling faster and more accurate testing for more than 60 analytes including steroid hormones, vitamin D and drugs of abuse...
Merck, a leading science and technology company, has signed a definitive agreement with the intention to acquire HUB Organoids Holding B.V. (HUB). Organoids are cell culture models that functionally resemble an organ. They have the potential to speed up drug development, improve understanding of disease treatment in diverse populations, and reduce the industry’s reliance on animal testing. HUB is a pioneer in the field of organoids...
Anton Paar is proud to introduce the Ultratap 500 series, an innovative leap in tap density testing. Engineered for durability, these instruments guarantee 25 million taps without calibration loss, setting a new industry standard. Backed by a robust three-year warranty, the Ultratap 500 series assures reliable performance for years, making it the most dependable choice for tap density analysis...
ZEISS partners with Mindpeak, a pioneer in AI-powered pathology solutions, to develop an integrated Multiplex Immunofluorescence (mIF) solution that serves pathologists across research, diagnostics, and clinical applications. Mindpeak’s expertise in AI-based image analysis of pathological tissues, particularly through its established algorithms for clinical routine applications, complements ZEISS's advanced instruments and software for research applications of mIF...
AMSBIO announce a new range of Synthetic Nanodiscs that enable preparation of multi-pass transmembrane proteins in their active form, revolutionizing the future of membrane protein research and drug development. Membrane Proteins account for more than 60% of all FDA-approved drug targets and 90% of antibody-based drug targets. Many traditional sample preparation methods struggle with challenges in obtaining water-soluble and bioactive forms of multi-pass transmembrane proteins...
In a new study, published in the journal Nature, researchers from EMBL Barcelona, the University of Texas, the University of Copenhagen, and The Scripps Research Institute have discovered human antibodies that can recognise and target some of the proteins that cause severe malaria. This breakthrough could pave the way for future vaccines or anti-malaria treatments...
AN influential cross-party Lords Committee has written to the Government to raise concerns about its preparedness for future pandemics, describing the current situation as “troubling”. In a letter to Pat McFadden, Chancellor of the Duchy of Lancaster, Baroness Brown of Cambridge, chair of the House of Lords Science and Technology Committee, said experts had raised “troubling concerns about (the UK’s) capacity to manufacture vaccines for future biological threats”...
Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, and a company of Danaher Corporation (NYSE: DHR), launches the Cydem VT Automated Clone Screening System, a revolutionary high-throughput microbioreactor platform for automated top clone screening. The new Cydem VT System significantly reduces time to market for biologic drug discovery and monoclonal antibody-based therapeutics, by slashing manual laboratory steps in Cell Line Development up to 90%...
Conducting quality control analysis in-house can offer time-saving benefits and help to control costs and protect confidential information. However, for companies that are not experienced in selecting an appropriate microscope, outsourcing SEM capabilities to a university or laboratory can be a tempting option. Here, Robbie O’Connell, Sales Account Manager (Electron Microscopy) at SEM specialist Thermo Fisher Scientific, offers advice on what to look for when purchasing an SEM for quality control purposes...
Sapio Sciences, the science-aware™ lab informatics platform, today announced the highly anticipated speaker lineup and agenda for SapioCon 2025. Taking place from February 26–28, 2025, at the Fort Lauderdale Marriott Harbor Beach Resort, the event will bring together leading experts in research and technology to explore the transformative role of AI and science-aware lab informatics in accelerating research, discovery, diagnostics, manufacturing, and business operations in the life sciences.
Agilent Technologies Inc. announces the new Mito-rOCR Assay Kit. This easy and streamlined end-to-end solution makes sophisticated analysis of mitochondrial function available to researchers of all skill levels. Whis cost-effective and versatile kit, researchers can easily incorporate functional assessment of relative mitochondrial respiration into their cell physiology and disease pathology studies...
INTEGRA Biosciences is excited to announce the launch of MAGFLO magnetic beads for precise and accurate nucleic acid purification, helping to ensure high recovery and maximum purity for next generation sequencing (NGS) and PCR protocols. These magnetic beads can be seamlessly combined with INTEGRA’s MAG or HEATMAG modules for magnetic separation and liquid handling systems for a complete nucleic acid preparation solution from a trusted provider...
Azenta, Inc. has announced the launch of a long-read Whole Genome Sequencing (WGS) test for clinical applications. Azenta becomes the first commercial provider to obtain regulatory approval to offer this test in the United States. Traditional short-read sequencing methods often struggle with identifying genetic variants in repetitive regions of the genome that underpin many rare diseases, hindering accurate diagnoses and targeted treatments...
PacBio, developer of the world’s most advanced sequencing technologies, has announced the Vega™ system, the company’s first benchtop long-read sequencing platform. Vega delivers all the functionality of the Revio system, PacBio’s high-throughput long-read sequencer, into a compact, lower-throughput benchtop platform. Offering exceptional data accuracy with HiFi technology, fast turnaround time, and a U.S. list price of $169,000...
AchemAsia is back: from 14 to 16 October 2025, the trade show in Shanghai will once again present itself as the leading platform for the Chinese process industry as well as the chemical and pharmaceutical sectors. As the ‘International Expo and Innovation Forum for Sustainable Chemical Production’, the focus will be on innovative technologies for a climate-neutral future, including process technology, pharmaceutical technology and digitalisation...
Astoriom, a global leader in the life sciences R&D sample stability and biorepository storage industry, has developed a new state-of-the-art cryogenic storage suite at its Tramore facility, bringing unmatched capabilities for biological sample storage to Ireland. Local representative Gerald Hurley, CEO of Waterford Chamber of Commerce, joined the Astoriom’s team for the company’s expansion into a new purpose built cryo suite, marking the significant milestone for the local community and Ireland’s growing life science sector...
Tracamyl has announced the acquisition of the Hektros brand formerly owned by Tratter Engineering. Hektros is the laboratory products entity of the plastic injection molding manufacturer Tratter Engineering. Tratter Engineering has a long-standing history in the automotive sector, being an important supplier of complex molded plastic parts for various car brands. Hektros develops and manufactures numerous devices and disposables for laboratory use in a broad range of chemical, biotechnological and medical-pharmaceutical fields....
Queensgate and the United Kingdom's National Metrology Institute have revealed their latest breakthrough at Euspen’s Special Interest Conference: Precision Motion Systems and Control in November. The development is a novel control system for a two-axis flexure stage with a 100 µm x 100 µm scanning range that enables high-speed atomic force microscopy (HS-AFM) over large areas. The result is an HS-AFM system capable of imaging large areas with molecular-level resolution...
Choosing a film for a movie night is always a battle. Now imagine if you could pick one that provided a window into some of the most fundamental biological processes that keep us alive. For the first time ever, researchers have captured a real-time molecular movie to show how two essential cellular processes – transcription and translation – interact with each other in bacteria...
Indica Labs, the global leader in AI-powered digital pathology, announces that the Institute of Tissue Medicine and Pathology at the University of Bern, a leading university based pathology institute in Switzerland, has selected HALO AP® for the Institute’s first-in-country digital pathology deployment in the cloud powered by Amazon Web Services, Inc. (AWS). The Institute selected Indica Labs for its ability to provide dependable, pathologist-centered software and AI in a powerful and highly flexible platform.
Biotech Fluidics reports that a major pharmaceutical customer has purchased 17 SPR-200 solvent recycler units to improve sustainable use of solvents by HPLC systems in their analytical laboratories. Externally powered, the standalone SPR-200 solvent recycler does not require an external computer thereby avoiding potential connectivity issues with user I.T systems. Compatible with most HPLC systems, the SPR-200 continuously monitors the output signal of liquid chromatography instrument detectors
The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, has announced the results of a global survey in conjunction with CCC (Copyright Clearance Center), a leader in advancing copyright, accelerating knowledge, and powering innovation, on the impact of AI and copyright legislation on pharma R&D. While 83% of life science professionals are now using generative AI in their research, there is still widespread concern about the impact of differing AI...
Roche Diagnostics received CE mark approval for its cobas® mass spectrometry solution, providing fully-automated, integrated, and standardised clinical mass spectrometry for laboratories worldwide. Until now, mass spectrometry has only been offered by specialist laboratories. This approval will broaden access to routine labs, enabling faster and more accurate testing for more than 60 analytes including steroid hormones, vitamin D and drugs of abuse...
Merck, a leading science and technology company, has signed a definitive agreement with the intention to acquire HUB Organoids Holding B.V. (HUB). Organoids are cell culture models that functionally resemble an organ. They have the potential to speed up drug development, improve understanding of disease treatment in diverse populations, and reduce the industry’s reliance on animal testing. HUB is a pioneer in the field of organoids...
Anton Paar is proud to introduce the Ultratap 500 series, an innovative leap in tap density testing. Engineered for durability, these instruments guarantee 25 million taps without calibration loss, setting a new industry standard. Backed by a robust three-year warranty, the Ultratap 500 series assures reliable performance for years, making it the most dependable choice for tap density analysis...
ZEISS partners with Mindpeak, a pioneer in AI-powered pathology solutions, to develop an integrated Multiplex Immunofluorescence (mIF) solution that serves pathologists across research, diagnostics, and clinical applications. Mindpeak’s expertise in AI-based image analysis of pathological tissues, particularly through its established algorithms for clinical routine applications, complements ZEISS's advanced instruments and software for research applications of mIF...
AMSBIO announce a new range of Synthetic Nanodiscs that enable preparation of multi-pass transmembrane proteins in their active form, revolutionizing the future of membrane protein research and drug development. Membrane Proteins account for more than 60% of all FDA-approved drug targets and 90% of antibody-based drug targets. Many traditional sample preparation methods struggle with challenges in obtaining water-soluble and bioactive forms of multi-pass transmembrane proteins...
In a new study, published in the journal Nature, researchers from EMBL Barcelona, the University of Texas, the University of Copenhagen, and The Scripps Research Institute have discovered human antibodies that can recognise and target some of the proteins that cause severe malaria. This breakthrough could pave the way for future vaccines or anti-malaria treatments...
AN influential cross-party Lords Committee has written to the Government to raise concerns about its preparedness for future pandemics, describing the current situation as “troubling”. In a letter to Pat McFadden, Chancellor of the Duchy of Lancaster, Baroness Brown of Cambridge, chair of the House of Lords Science and Technology Committee, said experts had raised “troubling concerns about (the UK’s) capacity to manufacture vaccines for future biological threats”...
Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, and a company of Danaher Corporation (NYSE: DHR), launches the Cydem VT Automated Clone Screening System, a revolutionary high-throughput microbioreactor platform for automated top clone screening. The new Cydem VT System significantly reduces time to market for biologic drug discovery and monoclonal antibody-based therapeutics, by slashing manual laboratory steps in Cell Line Development up to 90%...
Conducting quality control analysis in-house can offer time-saving benefits and help to control costs and protect confidential information. However, for companies that are not experienced in selecting an appropriate microscope, outsourcing SEM capabilities to a university or laboratory can be a tempting option. Here, Robbie O’Connell, Sales Account Manager (Electron Microscopy) at SEM specialist Thermo Fisher Scientific, offers advice on what to look for when purchasing an SEM for quality control purposes...
Sapio Sciences, the science-aware™ lab informatics platform, today announced the highly anticipated speaker lineup and agenda for SapioCon 2025. Taking place from February 26–28, 2025, at the Fort Lauderdale Marriott Harbor Beach Resort, the event will bring together leading experts in research and technology to explore the transformative role of AI and science-aware lab informatics in accelerating research, discovery, diagnostics, manufacturing, and business operations in the life sciences.
Agilent Technologies Inc. announces the new Mito-rOCR Assay Kit. This easy and streamlined end-to-end solution makes sophisticated analysis of mitochondrial function available to researchers of all skill levels. Whis cost-effective and versatile kit, researchers can easily incorporate functional assessment of relative mitochondrial respiration into their cell physiology and disease pathology studies...
INTEGRA Biosciences is excited to announce the launch of MAGFLO magnetic beads for precise and accurate nucleic acid purification, helping to ensure high recovery and maximum purity for next generation sequencing (NGS) and PCR protocols. These magnetic beads can be seamlessly combined with INTEGRA’s MAG or HEATMAG modules for magnetic separation and liquid handling systems for a complete nucleic acid preparation solution from a trusted provider...
Azenta, Inc. has announced the launch of a long-read Whole Genome Sequencing (WGS) test for clinical applications. Azenta becomes the first commercial provider to obtain regulatory approval to offer this test in the United States. Traditional short-read sequencing methods often struggle with identifying genetic variants in repetitive regions of the genome that underpin many rare diseases, hindering accurate diagnoses and targeted treatments...
PacBio, developer of the world’s most advanced sequencing technologies, has announced the Vega™ system, the company’s first benchtop long-read sequencing platform. Vega delivers all the functionality of the Revio system, PacBio’s high-throughput long-read sequencer, into a compact, lower-throughput benchtop platform. Offering exceptional data accuracy with HiFi technology, fast turnaround time, and a U.S. list price of $169,000...
AchemAsia is back: from 14 to 16 October 2025, the trade show in Shanghai will once again present itself as the leading platform for the Chinese process industry as well as the chemical and pharmaceutical sectors. As the ‘International Expo and Innovation Forum for Sustainable Chemical Production’, the focus will be on innovative technologies for a climate-neutral future, including process technology, pharmaceutical technology and digitalisation...
Astoriom, a global leader in the life sciences R&D sample stability and biorepository storage industry, has developed a new state-of-the-art cryogenic storage suite at its Tramore facility, bringing unmatched capabilities for biological sample storage to Ireland. Local representative Gerald Hurley, CEO of Waterford Chamber of Commerce, joined the Astoriom’s team for the company’s expansion into a new purpose built cryo suite, marking the significant milestone for the local community and Ireland’s growing life science sector...
Tracamyl has announced the acquisition of the Hektros brand formerly owned by Tratter Engineering. Hektros is the laboratory products entity of the plastic injection molding manufacturer Tratter Engineering. Tratter Engineering has a long-standing history in the automotive sector, being an important supplier of complex molded plastic parts for various car brands. Hektros develops and manufactures numerous devices and disposables for laboratory use in a broad range of chemical, biotechnological and medical-pharmaceutical fields....
Queensgate and the United Kingdom's National Metrology Institute have revealed their latest breakthrough at Euspen’s Special Interest Conference: Precision Motion Systems and Control in November. The development is a novel control system for a two-axis flexure stage with a 100 µm x 100 µm scanning range that enables high-speed atomic force microscopy (HS-AFM) over large areas. The result is an HS-AFM system capable of imaging large areas with molecular-level resolution...
Choosing a film for a movie night is always a battle. Now imagine if you could pick one that provided a window into some of the most fundamental biological processes that keep us alive. For the first time ever, researchers have captured a real-time molecular movie to show how two essential cellular processes – transcription and translation – interact with each other in bacteria...
Indica Labs, the global leader in AI-powered digital pathology, announces that the Institute of Tissue Medicine and Pathology at the University of Bern, a leading university based pathology institute in Switzerland, has selected HALO AP® for the Institute’s first-in-country digital pathology deployment in the cloud powered by Amazon Web Services, Inc. (AWS). The Institute selected Indica Labs for its ability to provide dependable, pathologist-centered software and AI in a powerful and highly flexible platform.
Biotech Fluidics reports that a major pharmaceutical customer has purchased 17 SPR-200 solvent recycler units to improve sustainable use of solvents by HPLC systems in their analytical laboratories. Externally powered, the standalone SPR-200 solvent recycler does not require an external computer thereby avoiding potential connectivity issues with user I.T systems. Compatible with most HPLC systems, the SPR-200 continuously monitors the output signal of liquid chromatography instrument detectors
The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, has announced the results of a global survey in conjunction with CCC (Copyright Clearance Center), a leader in advancing copyright, accelerating knowledge, and powering innovation, on the impact of AI and copyright legislation on pharma R&D. While 83% of life science professionals are now using generative AI in their research, there is still widespread concern about the impact of differing AI...